Hepatitis Forums
Advanced Liver Disease Main Forums => Advanced Liver Disease => Topic started by: Hep Editors on April 30, 2018, 11:11:01 am
-
Contrary to the findings of previous research, a new study has found that compared with receiving interferon-based treatment for hepatitis C virus (HCV), curative interferon-free direct-acting antiviral (DAA) therapy is not associated with an increased risk of developing hepatocellular carcinoma (HCC, the most common form of liver cancer) among people with cirrhosis, MedPage Today reports.
Publishing their findings in the Journal of Hepatology, researchers analyzed data on 857 people cured of hep C between 1997 and 2016. They all had been diagnosed with cirrhosis, none had yet been diagnosed with liver cancer and none were coinfected with hepatitis B virus (HBV) or HIV.
Read more...
https://www.hepmag.com/article/interferonfree-hep-c-treatments-linked-raised-liver-cancer-risk